NEW YORK (GenomeWeb) – Fitch Ratings has affirmed Thermo Fisher Scientific's ratings and its stable rating outlook.

The ratings apply to $12.5 billion of debt as of Dec. 31, 2015 and include BBB ratings for Thermo Fishers' long-term issuer default rating, senior notes, and a bank revolving credit facility; and F2 ratings for its short-term IDR and commercial paper. Fitch also affirmed a BBB rating for Thermo Fisher Subsidiary Life Technologies' long-term IDR and senior notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.